The Experts below are selected from a list of 5739 Experts worldwide ranked by ideXlab platform
Daniel Jaeck - One of the best experts on this subject based on the ideXlab platform.
-
splenic Vein inferior mesenteric Vein Anastomosis to lessen left sided portal hypertension after pancreaticoduodenectomy with concomitant vascular resection
Archives of Surgery, 2011Co-Authors: N Ferreira, Elie Oussoultzoglou, Pascal Fuchshuber, Dimitrios Ntourakis, Masato Narita, Mudassir Rather, Edoardo Rosso, Pietro Addeo, Patrick Pessaux, Daniel JaeckAbstract:Hypothesis A splenic Vein (SV)–inferior mesenteric Vein (IMV) Anastomosis reduces congestion of the stomach and spleen after pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence but carries a risk of left-sided venous hypertension. Design Comparative retrospective study. Setting Department of Digestive Surgery and Transplantation, University of Strasbourg, Strasbourg, France. Patients From January 1, 2002, to February 28, 2010, 39 patients underwent pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence for pancreatic adenocarcinoma. All patients had a terminoterminal portal Vein–superior mesenteric Vein Anastomosis. The SV blood flow into the portal Vein was preserved in 11 patients by reimplantation of the SV into the portal Vein. Sixteen patients underwent surgical reconstruction of the SV-IMV confluence by Anastomosis (group 1), and in 12 patients the natural SV-IMV confluence was preserved (group 2). Main Outcome Measures Preoperative and postoperative spleen volume and platelet count. Results Demographic characteristics, preoperative tumor staging, pathological outcome, and postoperative complications were comparable in both groups. There was no difference in platelet count between groups 1 and 2 preoperatively (mean [SD], 293.13 [125.37] vs 241.09 [49.12] × 10 3 /μL [to convert to ×10 9 /L, multiply by 1.0], respectively; P = .21) or postoperatively (mean [SD], 231.75 [156.39] vs 164.31 [76.46] × 10 3 /μL, respectively; P = .32). Likewise, no difference was found in the spleen volume preoperatively (mean [SD], 258.96 [179.23] vs 237.31 [122.46] mL, respectively; P = .76) and on postoperative day 15 (mean [SD], 279.08 [158.10] vs 299.12 [153.11] mL, respectively; P = .78). Conclusion Early assessment shows that SV-IMV Anastomosis is as feasible and as safe as the preservation of a natural SV-IMV confluence in patients undergoing pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.
-
Splenic Vein–Inferior Mesenteric Vein Anastomosis to Lessen Left-Sided Portal Hypertension After Pancreaticoduodenectomy With Concomitant Vascular Resection
Archives of surgery (Chicago Ill. : 1960), 2011Co-Authors: N Ferreira, Elie Oussoultzoglou, Pascal Fuchshuber, Dimitrios Ntourakis, Masato Narita, Mudassir Rather, Edoardo Rosso, Pietro Addeo, Patrick Pessaux, Daniel JaeckAbstract:Hypothesis A splenic Vein (SV)–inferior mesenteric Vein (IMV) Anastomosis reduces congestion of the stomach and spleen after pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence but carries a risk of left-sided venous hypertension. Design Comparative retrospective study. Setting Department of Digestive Surgery and Transplantation, University of Strasbourg, Strasbourg, France. Patients From January 1, 2002, to February 28, 2010, 39 patients underwent pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence for pancreatic adenocarcinoma. All patients had a terminoterminal portal Vein–superior mesenteric Vein Anastomosis. The SV blood flow into the portal Vein was preserved in 11 patients by reimplantation of the SV into the portal Vein. Sixteen patients underwent surgical reconstruction of the SV-IMV confluence by Anastomosis (group 1), and in 12 patients the natural SV-IMV confluence was preserved (group 2). Main Outcome Measures Preoperative and postoperative spleen volume and platelet count. Results Demographic characteristics, preoperative tumor staging, pathological outcome, and postoperative complications were comparable in both groups. There was no difference in platelet count between groups 1 and 2 preoperatively (mean [SD], 293.13 [125.37] vs 241.09 [49.12] × 10 3 /μL [to convert to ×10 9 /L, multiply by 1.0], respectively; P = .21) or postoperatively (mean [SD], 231.75 [156.39] vs 164.31 [76.46] × 10 3 /μL, respectively; P = .32). Likewise, no difference was found in the spleen volume preoperatively (mean [SD], 258.96 [179.23] vs 237.31 [122.46] mL, respectively; P = .76) and on postoperative day 15 (mean [SD], 279.08 [158.10] vs 299.12 [153.11] mL, respectively; P = .78). Conclusion Early assessment shows that SV-IMV Anastomosis is as feasible and as safe as the preservation of a natural SV-IMV confluence in patients undergoing pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.
N Ferreira - One of the best experts on this subject based on the ideXlab platform.
-
splenic Vein inferior mesenteric Vein Anastomosis to lessen left sided portal hypertension after pancreaticoduodenectomy with concomitant vascular resection
Archives of Surgery, 2011Co-Authors: N Ferreira, Elie Oussoultzoglou, Pascal Fuchshuber, Dimitrios Ntourakis, Masato Narita, Mudassir Rather, Edoardo Rosso, Pietro Addeo, Patrick Pessaux, Daniel JaeckAbstract:Hypothesis A splenic Vein (SV)–inferior mesenteric Vein (IMV) Anastomosis reduces congestion of the stomach and spleen after pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence but carries a risk of left-sided venous hypertension. Design Comparative retrospective study. Setting Department of Digestive Surgery and Transplantation, University of Strasbourg, Strasbourg, France. Patients From January 1, 2002, to February 28, 2010, 39 patients underwent pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence for pancreatic adenocarcinoma. All patients had a terminoterminal portal Vein–superior mesenteric Vein Anastomosis. The SV blood flow into the portal Vein was preserved in 11 patients by reimplantation of the SV into the portal Vein. Sixteen patients underwent surgical reconstruction of the SV-IMV confluence by Anastomosis (group 1), and in 12 patients the natural SV-IMV confluence was preserved (group 2). Main Outcome Measures Preoperative and postoperative spleen volume and platelet count. Results Demographic characteristics, preoperative tumor staging, pathological outcome, and postoperative complications were comparable in both groups. There was no difference in platelet count between groups 1 and 2 preoperatively (mean [SD], 293.13 [125.37] vs 241.09 [49.12] × 10 3 /μL [to convert to ×10 9 /L, multiply by 1.0], respectively; P = .21) or postoperatively (mean [SD], 231.75 [156.39] vs 164.31 [76.46] × 10 3 /μL, respectively; P = .32). Likewise, no difference was found in the spleen volume preoperatively (mean [SD], 258.96 [179.23] vs 237.31 [122.46] mL, respectively; P = .76) and on postoperative day 15 (mean [SD], 279.08 [158.10] vs 299.12 [153.11] mL, respectively; P = .78). Conclusion Early assessment shows that SV-IMV Anastomosis is as feasible and as safe as the preservation of a natural SV-IMV confluence in patients undergoing pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.
-
Splenic Vein–Inferior Mesenteric Vein Anastomosis to Lessen Left-Sided Portal Hypertension After Pancreaticoduodenectomy With Concomitant Vascular Resection
Archives of surgery (Chicago Ill. : 1960), 2011Co-Authors: N Ferreira, Elie Oussoultzoglou, Pascal Fuchshuber, Dimitrios Ntourakis, Masato Narita, Mudassir Rather, Edoardo Rosso, Pietro Addeo, Patrick Pessaux, Daniel JaeckAbstract:Hypothesis A splenic Vein (SV)–inferior mesenteric Vein (IMV) Anastomosis reduces congestion of the stomach and spleen after pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence but carries a risk of left-sided venous hypertension. Design Comparative retrospective study. Setting Department of Digestive Surgery and Transplantation, University of Strasbourg, Strasbourg, France. Patients From January 1, 2002, to February 28, 2010, 39 patients underwent pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence for pancreatic adenocarcinoma. All patients had a terminoterminal portal Vein–superior mesenteric Vein Anastomosis. The SV blood flow into the portal Vein was preserved in 11 patients by reimplantation of the SV into the portal Vein. Sixteen patients underwent surgical reconstruction of the SV-IMV confluence by Anastomosis (group 1), and in 12 patients the natural SV-IMV confluence was preserved (group 2). Main Outcome Measures Preoperative and postoperative spleen volume and platelet count. Results Demographic characteristics, preoperative tumor staging, pathological outcome, and postoperative complications were comparable in both groups. There was no difference in platelet count between groups 1 and 2 preoperatively (mean [SD], 293.13 [125.37] vs 241.09 [49.12] × 10 3 /μL [to convert to ×10 9 /L, multiply by 1.0], respectively; P = .21) or postoperatively (mean [SD], 231.75 [156.39] vs 164.31 [76.46] × 10 3 /μL, respectively; P = .32). Likewise, no difference was found in the spleen volume preoperatively (mean [SD], 258.96 [179.23] vs 237.31 [122.46] mL, respectively; P = .76) and on postoperative day 15 (mean [SD], 279.08 [158.10] vs 299.12 [153.11] mL, respectively; P = .78). Conclusion Early assessment shows that SV-IMV Anastomosis is as feasible and as safe as the preservation of a natural SV-IMV confluence in patients undergoing pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.
Zhuo Zhang - One of the best experts on this subject based on the ideXlab platform.
-
microsurgical spermatic inferior epigastric Vein Anastomosis for treating nutcracker syndrome associated varicocele in infertile men a preliminary experience
Urology, 2014Co-Authors: Muchun Zhang, Yang Jiang, Zhuo ZhangAbstract:Objective To assess the therapeutic effectiveness of microsurgical spermatic-inferior epigastric Vein Anastomosis for the treatment of nutcracker syndrome (NCS)-associated varicocele in infertile men. Methods We prospectively analyzed 5 infertile men with NCS-associated varicocele between April 2010 and January 2012. All patients underwent microsurgical spermatic-inferior epigastric Vein Anastomosis. Results The mean operation time was 85.0 ± 13.2 minutes, and the mean postoperative hospital stay was 6.0 ± 0.7 days. During a 1-year follow-up, hematuria completely resolved in 66.7% of patients (2/3) and flank pain resolved in the single patient affected. The peak velocity (PV) at the aortomesenteric portion of the left renal Vein (LRV) significantly decreased after surgery (167.24 ± 41.68 cm/s vs 46.98 ± 4.22 cm/s). The PV ratio between the aortomesenteric and hilar portion of the LRV also significantly decreased (12.28 ± 2.32 preoperatively vs 3.40 ± 0.67 postoperatively). The mean sperm count and motility at 6 months (24.38 × 10 6 /mL ± 1.58 × 10 6 /mL and 53.96% ± 6.28%, respectively) and 12 months (30.02 × 106/mL ± 3.52 × 106/mL and 59.40% ± 8.59%, respectively) postoperatively were significantly higher than their preoperative values (15.8 × 106/mL ± 4.53 × 106/mL and 26.76% ± 8.68%, respectively). Overall, 80% of the spouses of patients (4/5) went on to conceive naturally. The complications observed were scrotal edema in 1 patient (20%) and wound infection in 1 patient (20%). Conclusion Microsurgical spermatic-inferior epigastric Vein Anastomosis is a safe and efficient surgical treatment for infertile men with NCS-associated varicocele.
Rosaria Laporta - One of the best experts on this subject based on the ideXlab platform.
-
The axillary versus internal mammary recipient vessel sites for breast reconstruction with diep flaps: A retrospective study of 256 consecutive cases
Microsurgery, 2014Co-Authors: Fabio Santanelli Di Pompeo, Michail Sorotos, Benedetto Longo, Marco Pagnoni, Rosaria LaportaAbstract:The aim of this study is to present our experience on the use of various recipient sites for deep inferior epigastric perforator (DIEP) flap breast reconstruction and compare them by means of objective data. Two hundred fifty six DIEP flap breast reconstructions, performed between March 2004 and May 2011, were retrospectively analyzed. Only unilateral reconstructions were included in the study and divided into three groups depending on the recipient site choice: internal mammary vessels (IMV) (n = 52), thoracodorsal vessels (TDV) (n = 109), and circumflex scapular vessels (CSV) (n = 95). Clinical records of each patient were reviewed to acquire relevant data such as operative time, postoperative complications, and use of a second Vein Anastomosis. CSV group showed a statistically significant lower operative time (4.92 ± 0.54 hours) compared to TDV (5.67 ± 1.01 hours) and IMV groups (6.75 ± 1.09 hours) (P 0.05). The axillary vessels seem to be the ideal recipient site because of reduced operative time and increased possibility to perform a second Vein Anastomosis. Among them, CSV can be safely used due to following advantages: easy dissection, larger vessel caliber, and optimal flap insetting. Moreover, their location does not expose them completely to radiotherapy consequences. © 2014 Wiley Periodicals, Inc. Microsurgery 35:34–38, 2015.
-
Saline blow-assisted Vein Anastomosis.
Microsurgery, 2014Co-Authors: Fabio Santanelli Di Pompeo, Rosaria Laporta, Michail Sorotos, Benedetto LongoAbstract:[No abstract available
Masato Narita - One of the best experts on this subject based on the ideXlab platform.
-
splenic Vein inferior mesenteric Vein Anastomosis to lessen left sided portal hypertension after pancreaticoduodenectomy with concomitant vascular resection
Archives of Surgery, 2011Co-Authors: N Ferreira, Elie Oussoultzoglou, Pascal Fuchshuber, Dimitrios Ntourakis, Masato Narita, Mudassir Rather, Edoardo Rosso, Pietro Addeo, Patrick Pessaux, Daniel JaeckAbstract:Hypothesis A splenic Vein (SV)–inferior mesenteric Vein (IMV) Anastomosis reduces congestion of the stomach and spleen after pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence but carries a risk of left-sided venous hypertension. Design Comparative retrospective study. Setting Department of Digestive Surgery and Transplantation, University of Strasbourg, Strasbourg, France. Patients From January 1, 2002, to February 28, 2010, 39 patients underwent pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence for pancreatic adenocarcinoma. All patients had a terminoterminal portal Vein–superior mesenteric Vein Anastomosis. The SV blood flow into the portal Vein was preserved in 11 patients by reimplantation of the SV into the portal Vein. Sixteen patients underwent surgical reconstruction of the SV-IMV confluence by Anastomosis (group 1), and in 12 patients the natural SV-IMV confluence was preserved (group 2). Main Outcome Measures Preoperative and postoperative spleen volume and platelet count. Results Demographic characteristics, preoperative tumor staging, pathological outcome, and postoperative complications were comparable in both groups. There was no difference in platelet count between groups 1 and 2 preoperatively (mean [SD], 293.13 [125.37] vs 241.09 [49.12] × 10 3 /μL [to convert to ×10 9 /L, multiply by 1.0], respectively; P = .21) or postoperatively (mean [SD], 231.75 [156.39] vs 164.31 [76.46] × 10 3 /μL, respectively; P = .32). Likewise, no difference was found in the spleen volume preoperatively (mean [SD], 258.96 [179.23] vs 237.31 [122.46] mL, respectively; P = .76) and on postoperative day 15 (mean [SD], 279.08 [158.10] vs 299.12 [153.11] mL, respectively; P = .78). Conclusion Early assessment shows that SV-IMV Anastomosis is as feasible and as safe as the preservation of a natural SV-IMV confluence in patients undergoing pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.
-
Splenic Vein–Inferior Mesenteric Vein Anastomosis to Lessen Left-Sided Portal Hypertension After Pancreaticoduodenectomy With Concomitant Vascular Resection
Archives of surgery (Chicago Ill. : 1960), 2011Co-Authors: N Ferreira, Elie Oussoultzoglou, Pascal Fuchshuber, Dimitrios Ntourakis, Masato Narita, Mudassir Rather, Edoardo Rosso, Pietro Addeo, Patrick Pessaux, Daniel JaeckAbstract:Hypothesis A splenic Vein (SV)–inferior mesenteric Vein (IMV) Anastomosis reduces congestion of the stomach and spleen after pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence but carries a risk of left-sided venous hypertension. Design Comparative retrospective study. Setting Department of Digestive Surgery and Transplantation, University of Strasbourg, Strasbourg, France. Patients From January 1, 2002, to February 28, 2010, 39 patients underwent pancreaticoduodenectomy with resection of the SV–mesenteric Vein confluence for pancreatic adenocarcinoma. All patients had a terminoterminal portal Vein–superior mesenteric Vein Anastomosis. The SV blood flow into the portal Vein was preserved in 11 patients by reimplantation of the SV into the portal Vein. Sixteen patients underwent surgical reconstruction of the SV-IMV confluence by Anastomosis (group 1), and in 12 patients the natural SV-IMV confluence was preserved (group 2). Main Outcome Measures Preoperative and postoperative spleen volume and platelet count. Results Demographic characteristics, preoperative tumor staging, pathological outcome, and postoperative complications were comparable in both groups. There was no difference in platelet count between groups 1 and 2 preoperatively (mean [SD], 293.13 [125.37] vs 241.09 [49.12] × 10 3 /μL [to convert to ×10 9 /L, multiply by 1.0], respectively; P = .21) or postoperatively (mean [SD], 231.75 [156.39] vs 164.31 [76.46] × 10 3 /μL, respectively; P = .32). Likewise, no difference was found in the spleen volume preoperatively (mean [SD], 258.96 [179.23] vs 237.31 [122.46] mL, respectively; P = .76) and on postoperative day 15 (mean [SD], 279.08 [158.10] vs 299.12 [153.11] mL, respectively; P = .78). Conclusion Early assessment shows that SV-IMV Anastomosis is as feasible and as safe as the preservation of a natural SV-IMV confluence in patients undergoing pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.
